Latest Regulatory News

Kore Potash Plc's shares have been suspended from trading on the ASX after the company missed its deadline to lodge a draft financing proposal for the Kola Project. The suspension follows a prior trading halt and will remain until regulatory compliance is restored.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

AdAlta Limited has announced a renounceable rights issue to raise up to $1.3 million, aiming to accelerate its ‘East to West’ cellular immunotherapy strategy and explore new strategic options.

Southern Cross Gold Consolidated Ltd has successfully arranged a C$143 million private placement, positioning the company to accelerate development of its Sunday Creek Gold-Antimony Project in Victoria, Australia.

Blackstone Minerals and IDM International have reported impressive assay results from drillhole CDH-61 at the Mankayan copper-gold porphyry project, confirming over 300 metres of high-grade mineralisation and a robust high-grade core. This milestone reinforces Mankayan's status as a world-class undeveloped copper-gold asset with significant development optionality.

The ASX has suspended the securities of Aneka Tambang, MCS Services, and Metalstech due to failure to lodge periodic reports on time, signaling regulatory enforcement and potential market impacts.

A1 Investments & Resources Limited reported negative operating cash flows and no business activity in Q1 2025, drawing down $200,000 of a $300,000 loan as it seeks a transaction to regain ASX listing status.

Dimerix Limited has announced a US licensing transaction for its Phase 3 asset DMX-200 targeting FSGS, alongside progress updates on its clinical trial. The move underscores the company’s push to address a rare kidney disease with no approved therapies.

Dimerix has inked an exclusive US licensing agreement with Amicus Therapeutics for DMX-200, a promising Phase 3 treatment for FSGS, unlocking $30 million upfront and up to $560 million in milestones.

Assetora Limited has dramatically reduced its net liabilities and strengthened its balance sheet through strategic capital raises and debt conversions, while unveiling a comprehensive rebrand and leadership expansion to drive its next growth phase.

Pilot Energy confirms regulatory compliance and operational progress at the Head Field, advancing the repurposing of Cliff Oil infrastructure into a carbon storage facility as part of the Mid West Clean Energy Project.

Imricor Medical Systems has initiated its first MRI-guided atrial flutter ablation procedures at Semmelweis University in Budapest, marking a significant expansion of its real-time MRI technology in Europe.